Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Cancer Biologic Trials

Research area

Melanoma biologic therapy trials

The melanoma studies on this site all test a biologic, such as a vaccine, an antibody, or a cell or gene therapy. Whether you are looking for yourself or for someone you care for, Cancer Biologic Trials can help you find out if a study may be a fit.

Updated

Call (888) 343-5902
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Melanoma biologic therapy studies in numbers

melanoma biologic therapy studies recruiting in the U.S.
48
states with a study site
45

Source: ClinicalTrials.gov. Data processed .

Find melanoma biologic therapy studies by state

These states have the most studies recruiting right now.

Melanoma biologic therapy studies recruiting now

As of November 18, 2026, 48 melanoma biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.

What they test

  • biologics such as vaccines or antibodies48
  • medications21
  • procedures10
  • other approaches4
  • devices3

A study can test more than one.

Main purpose

  • treating a condition46
  • other purposes1
  • supportive care1

Phase

  • Early Phase 11
  • Phase 118
  • Phase 1/219
  • Phase 25
  • Phase 2/32
  • Phase 33

Who runs them

  • industry26
  • university, hospital or other18
  • government4

Who they enroll

  • adults (18 to 64)47
  • older adults (65 and over)46
  • mainly children and teens (under 18)2

These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.

Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 48 studies.

Recently updated melanoma biologic therapy studies

The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.

  1. BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    National Cancer Institute (NCI)
    Recruiting in
    Albuquerque, NM · Alexandria, VA · Ames, IA · and 163 more U.S. locations
    Registry record
    NCT05136196 · updated
  2. Memory-Like Natural Killer Cells With Nivolumab and Relatlimab in Advanced or Metastatic Melanoma After Progression on Checkpoint Inhibitors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Recruiting in
    St Louis, MO
    Registry record
    NCT05629546 · updated
  3. A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

    • Phase 1/2
    • From 6 months, up to 17 years
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Recruiting in
    Aurora, CO · Boston, MA · Chicago, IL · and 4 more U.S. locations
    Registry record
    NCT02332668 · updated
  4. A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

    • Phase 1
    • Ages 18 and older
    • Female participants
    Sponsor
    Outpace Bio, Inc.
    Recruiting in
    Atlanta, GA · Detroit, MI · Houston, TX · and 2 more U.S. locations
    Registry record
    NCT07664735 · updated
  5. Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)

    • Phase 1
    • Ages 3 to 25
    • All sexes
    Sponsor
    Children's National Research Institute
    Recruiting in
    Washington D.C., DC
    Registry record
    NCT07796061 · updated
  6. A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Duke University
    Recruiting in
    Durham, NC
    Registry record
    NCT05077137 · updated

Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in the United States on ClinicalTrials.gov.

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.

Cancer Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

What melanoma biologic therapy studies look at

Every melanoma study listed here tests a biologic: a vaccine, an antibody, or a cell or gene therapy, for example. No two are quite alike. Because each one is built to answer a single specific question, what you or the person you care for would be asked to do changes from one study to the next.

Anything tested in a study is investigational, and that includes the biologic in each of these. Researchers are still learning how well it works and what risks it carries. That is why the study is being run in the first place.

Who may be able to take part

No two melanoma biologic therapy trials set the same entry requirements. A study may consider your age, the medications you take now, your health history, and the ways melanoma affects you. People without the condition are enrolled in some studies too.

Sorting out whether you or a family member fits is not your job. That gets checked by the study team when you come in for a screening visit. Our guide to eligibility and screening explains the process.

What taking part usually involves

  1. A first conversation

    The first step is a conversation. A coordinator describes the melanoma biologic study in general terms and answers your questions, or your family's, before anything else happens.

  2. Informed consent

    Every detail of the biologic study reaches you in writing, and that includes the risks already known. The document comes from the study team. Whether to agree is entirely your call.

  3. Screening

    Screening is how the team finds out if a melanoma biologic study suits you. It involves health questions and some tests. Some people who go through screening do not end up joining the study.

  4. Study visits

    Joining means coming in for visits set in advance, which is how the team follows your health during the biologic study. Leaving is always allowed. You are free to step out at any point.

Questions about melanoma biologic therapy studies

Do I need a diagnosis to join a study about melanoma?

Each melanoma biologic study sets its own rule on this. For some, your diagnosis has to be confirmed already. Others evaluate you as part of screening. Whichever applies to you, the study team will say so.

Would I have to change the care I receive now?

Nothing about your current melanoma care should be altered on your own. Each biologic study sets its own rule here: some let existing care carry on, some do not. The study doctor goes over your situation with you. There is also room to speak with your regular doctor before you make up your mind.

Is there a cost to take part?

In general, participants are not charged for the visits and tests a study requires, or for the study medication itself. Our page on costs has more detail.

Ask about melanoma biologic therapy studies

A coordinator will reach out once you send a few details, whether the melanoma biologic study would be for you or for a family member. You are only asking. Nothing is committed.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Independent information

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 343-5902

or send a short form

How should we reach you?

Call